Open Access<p>Elevated Pulmonary Artery Systolic Pressure is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer</p>
Author(s) -
Xue Yang,
Lina Wang,
Lin Li,
Xinmin Liu
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s260857
Subject(s) - medicine , lung cancer , pulmonary artery , pulmonary hypertension , cardiology , metastasis , proportional hazards model , hazard ratio , cancer , blood pressure , lung , oncology , gastroenterology , confidence interval
Pulmonary hypertension (PH) is an important comorbidity of lung cancer, PH in lung cancer patients is gradually gaining interest because of its apparent high prevalence, but the impact of PH on the outcomes of lung cancer remains uncertain and had rarely been discussed. We aimed to evaluate the prevalence, determinants and prognosis value of elevated pulmonary artery systolic pressure (PASP) in non-small cell lung cancer patients.